Preparation and In Vivo Efficacy Study of Pancreatin Microparticles as an Enzyme Replacement Therapy for Pancreatitis

Author： Naikwade Sonali Raosaheb   Meshram Rupali Namdeo   Bajaj Amrita Narayan  

Publisher： Informa Healthcare

ISSN： 0363-9045

Source： Drug Development and Industrial Pharmacy, Vol.35, Iss.4, 2009-04, pp. : 417-432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis

By Littlewood James M   Connett Gary J   Sander-Struckmeier Suntje   Henniges Friederike  

Expert Opinion on Drug Safety, Vol. 10, Iss. 2, 2011-03 ,pp. : 197-203

Informa Healthcare

Access to resources Recommend Favorite

Agalsidase alfa – a preparation for enzyme replacement therapy in Anderson–Fabry disease

By Beck Michael  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 851-858

Informa Healthcare

Access to resources Recommend Favorite

Enzyme replacement therapy for the mucopolysaccharide storage disorders

By Kakkis Emil  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 5, 2002-05 ,pp. : 675-685

Informa Healthcare

Access to resources Recommend Favorite

Enzyme Replacement Therapy in Patients with Fabry's Disease

By Tsuboi K  

The Journal of International Medical Research, Vol. 35, Iss. 4, 2007-07 ,pp. : 574-581

Field House Publishing

Access to resources Recommend Favorite

Fabry disease: recent advances in enzyme replacement therapy

By Germain Dominique P  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 10, 2002-10 ,pp. : 1467-1476

Informa Healthcare

Access to resources Recommend Favorite